Weill Cornell Medicine’s debt-reduction program was created in 2019 to cover tuition, fees, housing and living expenses for students with financial need.
On Oct. 26, Cornell administrators will sign the Okanagan Charter, a formal pledge to promote health and well-being across all facets of university life.
The Big Red Adaptive Play and Design Initiative has brought independence and joy to local children with disabilities – and has created space for the engineering of assistive technologies at Cornell.
Researchers from Weill Cornell Medicine and colleagues found that two-dose vaccines still provide protection against lung disease in rhesus macaques a year after they had been vaccinated as infants.
The activity of a gene called CIART is a key factor in the establishment of the viral infection that causes COVID-19, according to a study from researchers at Weill Cornell Medicine and New York University Grossman School of Medicine.
MicroRNA (miRNA) molecules in pancreatic islets have been thought to play important roles in Type 2 diabetes, but until now scientists have not confidently identified which miRNAs are associated with the disease in humans.
The CDC confirmed a new Delta subtype – ‘AY.4.2.’ – has been identified for the first time in the United States after increasing frequency in the U.K. Health officials say it is still very rare.
The research from the Boyce Thompson Institute focuses on neurotransmitter serotonin, which carries messages between nerve cells and is thought to play a role in several mental health conditions.
Ithaca-based SimpliFed – a virtual platform providing personalized advice, service and support to parents – is responding to the baby formula shortage by offering free expert advice and hosting a free virtual class to help new parents prepare for feeding their babies.
Nearly 90% of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
